Ratain MJ - Search Results

1

The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CK. de Souza JA, et al. Among authors: ratain mj. Cancer. 2014 Oct 15;120(20):3245-53. doi: 10.1002/cncr.28814. Epub 2014 Jun 20. Cancer. 2014. PMID: 24954526 Free article.

2

A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.

Vogelzang NJ, Karrison T, Stadler WM, Garcia J, Cohn H, Kugler J, Troeger T, Giannone L, Arrieta R, Ratain MJ, Vokes EE. Vogelzang NJ, et al. Among authors: ratain mj. Cancer. 2004 Jan 1;100(1):65-71. doi: 10.1002/cncr.11867. Cancer. 2004. PMID: 14692025 Free article. Clinical Trial.

3

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. Odenike OM, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 2004 Dec;54(6):553-61. doi: 10.1007/s00280-004-0857-3. Epub 2004 Sep 2. Cancer Chemother Pharmacol. 2004. PMID: 15349753 Clinical Trial.

4

Measuring response in a post-RECIST world: from black and white to shades of grey.

Michaelis LC, Ratain MJ. Michaelis LC, et al. Among authors: ratain mj. Nat Rev Cancer. 2006 May;6(5):409-14. doi: 10.1038/nrc1883. Nat Rev Cancer. 2006. PMID: 16633367 Review.

5

Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.

Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Hlubocky FJ, et al. Among authors: ratain mj. J Clin Oncol. 2007 Feb 10;25(5):548-54. doi: 10.1200/JCO.2005.03.9800. J Clin Oncol. 2007. PMID: 17290064

6

Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.

Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CK. Gray SW, et al. Among authors: ratain mj. J Clin Oncol. 2007 Aug 10;25(23):3488-94. doi: 10.1200/JCO.2007.11.7283. J Clin Oncol. 2007. PMID: 17687154

7

Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.

Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RL. Daugherty CK, et al. Among authors: ratain mj. J Clin Oncol. 2008 Mar 10;26(8):1371-8. doi: 10.1200/JCO.2007.13.5335. Epub 2008 Jan 28. J Clin Oncol. 2008. PMID: 18227527 Review.

8

Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies.

Sharma MR, Maitland ML, Ratain MJ. Sharma MR, et al. Among authors: ratain mj. Cancer J. 2009 Sep-Oct;15(5):426-30. doi: 10.1097/PPO.0b013e3181b9c5d5. Cancer J. 2009. PMID: 19826363 Review.

9

Analysis of the yield of phase II combination therapy trials in medical oncology.

Maitland ML, Hudoba C, Snider KL, Ratain MJ. Maitland ML, et al. Among authors: ratain mj. Clin Cancer Res. 2010 Nov 1;16(21):5296-302. doi: 10.1158/1078-0432.CCR-10-0669. Epub 2010 Sep 13. Clin Cancer Res. 2010. PMID: 20837695 Free PMC article. Review.

10

Value-based insurance design in oncology.

de Souza JA, Polite BN, Manning WG, Fendrick AM, Ratain MJ. de Souza JA, et al. Among authors: ratain mj. Lancet Oncol. 2011 Apr;12(4):321-3. doi: 10.1016/S1470-2045(11)70043-2. Lancet Oncol. 2011. PMID: 21463832 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters